BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2023 7:03:16 AM | Browse: 233 | Download: 1051
 |
Received |
|
2022-09-18 13:14 |
|
Peer-Review Started |
|
2022-09-18 13:18 |
|
First Decision by Editorial Office Director |
|
2022-11-11 02:24 |
|
Return for Revision |
|
2022-11-11 02:24 |
|
Revised |
|
2022-11-25 06:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-01-28 03:15 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-28 06:03 |
|
Articles in Press |
|
2023-01-28 06:03 |
|
Edit the Manuscript by Language Editor |
|
2023-01-24 13:32 |
|
Typeset the Manuscript |
|
2023-01-30 09:28 |
|
Publish the Manuscript Online |
|
2023-02-14 07:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Angioimmunoblastic T-cell lymphoma induced hemophagocytic lymphohistiocytosis and disseminated intravascular coagulopathy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mei Jiang, Jing-Hua Wan, Yi Tu, Yan Shen, Fan-Cong Kong and Zhang-Lin Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82160692 and No. 82160037 |
|
| Corresponding Author |
Zhang-Lin Zhang, Doctor, Associate Chief Technician, Department of Transfusion, The First Affiliated Hospital of Nanchang University, No. 17 Yongwai Street, Nanchang 330006, Jiangxi Province, China. ndyfy02270@ncu.edu.cn |
| Key Words |
Angioimmunoblastic T-cell lymphoma; Hemophagocytic lymphohistiocytosis; Disseminated intravascular coagulopathy; Prognostic factors; Case report |
| Core Tip |
Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma, with heterogenous clinical manifestations and poor prognosis. Early diagnosis is particularly important. Herein, we report a patient with AITL induced hemophagocytic lymphohistiocytosis (HLH) and disseminated intravascular coagulopathy (DIC). The patient rapidly succumbed to gastrointestinal bleeding and septic shock. The time between onset and death was about one month. To the best of our knowledge, this is the first case of AITL induced HLH and DIC. AITL is more aggressive in older adults. In addition to male gender, mediastinal lymphadenopathy, anaemia, and sustained high level of neutrophil-to-lymphocyte ratio may indicate a greater risk of death. Early diagnosis, early detection of severe complications, and prompt and effective treatment are vital. |
| Publish Date |
2023-02-14 07:03 |
| Citation |
Jiang M, Wan JH, Tu Y, Shen Y, Kong FC, Zhang ZL. Angioimmunoblastic T-cell lymphoma induced hemophagocytic lymphohistiocytosis and disseminated intravascular coagulopathy: A case report. World J Clin Cases 2023; 11(5): 1086-1093 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i5/1086.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i5.1086 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
